Rolando Garcia, Ph.D.

Rolando García, PhD, FACMG is board-certified in Laboratory Genetics and Genomics by the American Board of Medical Genetics and Genomics (ABMGG). He completed his fellowship training in Clinical Genetics and Genomics at UT Southwestern before joining the faculty as an Assistant Professor of Pathology, where he assumed responsibilities in cytogenetics, microarray and next generation sequencing (NGS). Dr. Garcia is a fellow of the American College of Medical Genetics (ACMG). His research interests include clinical genetics and genomics, hematolymphoid neoplasms, with multiple published studies in these areas. His current work focuses on developing novel marker panels integrated with computational analysis to improve diagnosis, prognostic profiling of myeloid and lymphoid disorders, and identification of therapeutic targets.

Key Publications

Koduru P, Chen W, Fuda F, Pacheco M, Garcia R. MYC-r with a non-IG partner concurrently with a cryptic t(12;21) in B-lymphoblastic leukemia: A case and prognostic significance. Cancer Genet. 2025 Feb 15;292-293:85-91

Wright CA, Scheuerle AE, Wilson K, García R, Koduru P. Phenotypic and genotypic insights into concurrent tertiary trisomy for 9p and 18p. Mol Cytogenet. 2025 Feb 10;18(1):1

García R, Alkayyali T, Gomez LM, Wright C, Chen W, Oliver D, Koduru P. Recurrent cytogenetic abnormalities reveal alterations that promote progression and transformation in myelodysplastic syndrome. Cancer Genet. 2024 Nov;288-289:92-105

García R, Atis M, Cox A, Koduru P. Structural screening and molecular simulation identify potential ligands against the K700E hot spot variant and functional pockets of SF3B1 to modulate splicing in myelodysplastic syndrome. Heliyon. 2024 Jun 10;10(12):e32729

Koduru P, Chen W, Fuda F, Kaur G, Awan F, John S, Garcia R, Gagan. RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic Malignancies. J.Clin Pathol. 2024 Feb 1